Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
About Health Canada
Access to Information Requests Completed - July 2013
The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
Acronyms
- AER
- Adverse Reaction Report (Adverse Event)
- DIN
- Drug Identification Number
- DIN-HM
- Homeopathic Medicine Number
- NPN
- Natural Product Number
| Request # | Summary of Requests | Status of Completed Request | Number of Pages Disclosed |
|---|---|---|---|
| A-2010-01573 | All reports and evaluations related to the investigation and risk management of the recall entitled: "Updated Information Regarding Recalled Infant and Children Motrin and Tylenol Products" (Information Update, 2010-67, May 4, 2010). | Disclosed in part | 1,586 |
| A-2011-00583 | Information regarding the medical device SCULPTRA POLY-L-LACTIC ACID DERMAL IMPLANT by Sanofi-Aventis. | Disclosed in part | 493 |
| A-2011-01436 | Information regarding the product Reishi Mushroom; Immune Strengthener, NPN 80002477 by Canadian NHPs Enterprises Corp. | Disclosed in part | 52 |
| A-2011-01473 | Information regarding the NPN 80006418. | Disclosed in part | 108 |
| A-2011-01523 | Information regarding the product Ceretec by Amersham Corporation Ltd. | Disclosed in part | 362 |
| A-2011-01533 | All correspondence, between Apotex Inc. and the Minister of Health relating to any Supplemental Abbreviated New Drug Submissions or Notifiable Changes Submission pertaining to Apotex Inc.'s generic Atomoxetine drug. (Oct 10, 2008 to Feb 22, 2012). | Disclosed in part | 253 |
| A-2011-01736 | Information regarding the product Latisse by Allergan Inc. | Disclosed in part | 44 |
| A-2012-00858 | Documents about the proposed changes to the Marihuana Medical Access Regulations relating to requirements for set up of Licensed Commercial Producers. | Disclosed in part | 737 |
| A-2012-00994 | Documentation related to the planning and implementation of British Columbia Tripartite First Nations Health (BC Tripartite). (Apr 1, 2007 to Mar 31, 2012). | Disclosed in part | 554 |
| A-2012-01066 | Documents produced by the federal government to reach decisions on risk management measures for the following substances:
(Jan 1, 2006 to Nov 15, 2012) |
Disclosed in part | 396 |
| A-2012-01075 | Documents concerning complaints or enforcement activities relating to drug companies advertising on social media platforms. (Jan 1, 2012 to Oct 29, 2012). | Disclosed in part | 228 |
| A-2012-01163 | All correspondence with representatives of the Quebec Coalition on Weight-Related Problems (La Coalition Poids). (Jan 1 2011 to Nov 21, 2012). | Disclosed in part | 848 |
| A-2012-01164 | Correspondence with representatives of the Centre for Science in the Public Interest (CSPI). (Jan 1, 2011 to Nov 21, 2012). | Disclosed in part | 217 |
| A-2012-01205 | Correspondence between Health Canada and the Canadian Beverage Association regarding energy/caffeinated drinks. (Oct 1, 2011 to Nov 27, 2012). | Disclosed in part | 227 |
| A-2012-01421 | All correspondence relating to the selection of external and/or internal advisors, members, participants, and/or consultants of the Health Canada Medical Marihuana Regulations. (Jan 02, 2010 to Dec 01, 2012). | Disclosed in part | 59 |
| A-2012-01502 | Communications received by Health Canada concerning problems with ACTOS (and other prescription drugs sold in Canada) regarding issuance of public warnings, communications made to health care professionals, complaints from the public and information concerning harmful interactions. | Disclosed in part | 407 |
| A-2012-01587 | Release of the 2012 final report on the'Socio-economic Data Related to certain activities and sources of exposure to lead in Canada prepared for Health Canada's Healthy Environments and Consumer Safety Branch. | Disclosed in part | 331 |
| A-2012-01637 | All documents relating to the Standards Council of Canada's plans and consultations to revise the National Standards System and accredit new Standards Development Organizations. (Nov 1, 2011 to Feb 26, 2013). | Disclosed in part | 47 |
| A-2012-01654 | AERs for the product Coversyl. Report numbers: 000429150, 000435851, 000438246, 000442005, 000450815, 000454611, 000455147, 000422333, 000464430 and 000468602. | Disclosed in part | 23 |
| A-2012-01675 | All documents regarding the addition of synthetic, cannabinoids and products labelled IZMS to the Controlled Drugs and Substances Act (Jan 1, 2011 to Mar 7, 2013). | Disclosed in part | 96 |
| A-2012-01680 | All documents relating to Identifying the Government of Canada's priorities and goals for the development of standards of the existing National Standards System to meet the policy goals of the Government of Canada related to standards development. (Nov 1, 2011 to Feb 26, 2013). | Disclosed in part | 860 |
| A-2012-01698 | Copy of all the documents related to the market release of tobacco products by CT Brands Holdings Ltd. and Canada Tobacco & Global Inc. (Jan 1, 2010 to Mar 7, 2013). | Disclosed in part | 76 |
| A-2013-00019 | AERs for the product Pradaxa. | Disclosed in part | 14 |
| A-2013-00035 | All statistics or data showing the number of complaints received by product categories. (Jan 1, 2006 to Apr 16, 2013). | Disclosed in part | 10 |
| A-2013-00054 | Information regarding the following products:
|
Disclosed in part | 155 |
| A-2013-00056 | Information regarding the following products:
|
Disclosed in part | 208 |
| A-2013-00061 | Information regarding the following products:
|
Disclosed in part | 330 |
| A-2013-00063 | Information regarding the product Homeodel 9, DIN-HM 80023185. | Disclosed in part | 70 |
| A-2013-00066 | Information regarding the product Spir-Sec, DIN-HM 80029114 by Natural World Distribution. | Disclosed in part | 65 |
| A-2013-00138 | AER. Report number: 000478155. | All disclosed | 3 |
| A-2013-00139 | AER. Report number: 000478356. | All disclosed | 3 |
| A-2013-00140 | AER. Report number: 000478367. | All disclosed | 2 |
| A-2013-00141 | AER. Report number: 000491399. | Disclosed in part | 2 |
| A-2013-00142 | AER. Report number: 000491529. | Disclosed in part | 6 |
| A-2013-00145 | AER. Report number: 000489253. | Disclosed in part | 2 |
| A-2013-00171 | Copy of the contract and the full report following the inquiry conducted by AGL INVESTIGATION CONSULTING INC. | Disclosed in part | 37 |
| A-2013-00206 | AER for the product Humulin. Report number: 000476676. | Disclosed in part | 6 |
| A-2013-00209 | AERs for the product Alimta. Report numbers: 000484388 and 000470277. | Disclosed in part | 8 |
| A-2013-00219 | Documents related to positions under Non-Insured Health Benefits for First Nations and Inuit that are currently active and how many have been affected by the Work Force adjustment. (Jan 1, 2009 to May 15, 2013) | Disclosed in part | 155 |
| A-2013-00236 | AER. Report number: 000473826. | Disclosed in part | 3 |
| A-2013-00239 | AERs. Report numbers: 000452341, 000456667, 000448915 and 000485275. | Disclosed in part | 6 |
| A-2013-00252 | AERs for the product BIAXIN. Report numbers: 000473192, 000476652 and 000476690. | Disclosed in part | 4 |
| A-2013-00254 | AERs for the product Epival. Report numbers: 000479893 and 000468992. | Disclosed in part | 3 |
| A-2013-00261 | Copy of the code of conduct for employees' presentations related to dissemination of the code to staff. (Apr 1 2012 to May 29, 2013). | All disclosed | 25 |
| A-2013-00272 | All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of May 2013. | Disclosed in part | 67 |
| A-2013-00273 | Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during May 2013. | All disclosed | 4 |
| A-2013-00278 | List of all the studies conducted by the Applied Research and Analysis Directorate. (Jan 1, 2011 to Mar 28, 2013). | Disclosed in part | 3 |
| A-2013-00284 | Documents relating to disparities between Canada and the USA of pest control products, discussions for loosening regulatory standards to permit more US pest control products' entry into Canada. (Jan 1, 2012 to Jun 5, 2013). | No records exist | 0 |
| A-2013-00291 | AERs for the product WinRho SDF. Report numbers: 000463192, 000463198 and 000462144. | Disclosed in part | 10 |
| A-2013-00304 | All annual reviews and program plans produced by Health Canada for the Employee Assistance Services (EAS). (Jun 1, 2011 to Jun 11, 2013). | All disclosed | 19 |
| A-2013-00332 | Documents about the Marihuana Medical Access Regulations (MMAR) and the Marihuana for Medical Purposes Regulations relating to the total annual dried cannabis dosage or consumption of Authorization to Possess licensees under the MMAR. | All disclosed | 1 |
| A-2013-00333 | AER for the product JEVTANA. Report number: 000476658. | Disclosed in part | 1 |
| A-2013-00335 | All documents of notification of health impairment and/or health effects submitted by Canadian Developers and TransAtla, the manufacturer of GE 1.5 and any importer of a radiation emitting device for the Melanchthon Phase II industrial wind turbines project. (Nov 1, 2008 to Jun 20, 2013). | No records exist | 0 |
| A-2013-00371 | AER for the product Synagis. Report number: 000401440. | Disclosed in part | 1 |
| A-2013-00374 | AERs for the product Lupron. Report numbers: 000453413, 000458542 and 000475267. | Disclosed in part | 5 |
| A-2013-00377 | AER for the product Kaletra. Report number: 000462670. | Disclosed in part | 3 |
| A-2013-00378 | All reviews and reports into the Microbiological Emergency Response Team unit. | No records exist | 0 |
| A-2013-00396 | Copy of draft and final reports, as well as outlines of key conditions from Deloitte's assessment of the Deficit Reduction Plan/Strategic Operating Review. | No records exist | 0 |
| A-2013-00398 | All call-ups and contracts processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of June 2013. | Disclosed in part | 54 |
| A-2013-00399 | Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during June 2013. | All disclosed | 3 |
